Back to company

ACUPHARMA ApS: Financial statements 2022

CVR: 10072956

ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 778,365 and a net result of DKK -449,629 compared with DKK 6,046 the year before. That is a decrease of 34.3% compared with the year before. Equity amounted to DKK -291,353. The company had 2 employees in the financial year.

Gross Profit
778,365 kr.
Profit/Loss
-449,629 kr.
Equity
-291,353 kr.
Total Assets
2,010,882 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-778 t.-450 t.-291 t.2
2021-1.2 mio.6 t.158 t.3
2020-1.4 mio.-235 t.152 t.3
2019-1.7 mio.33 t.387 t.4
2018-1.7 mio.5 t.154 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ACUPHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

ACUPHARMA ApS: The 2021 annual report is outFeb 4, 2022

ACUPHARMA ApS has published its annual report for 2021. Gross profit came to DKK 1,184,849, and the net result was DKK 6,046.

About ACUPHARMA ApS

ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees. In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity amounted to DKK -109,301.